90
Participants
Start Date
October 30, 2019
Primary Completion Date
April 30, 2024
Study Completion Date
April 30, 2024
Fostamatinib disodium
Fostamatinib is supplied in two (2) dosage strengths: 100 mg and 150 mg.
Hanusch-Krankenhaus, Vienna
University Multiprofile Hospital for Active Treatment Sv. Ivan Rilski EAD, Varna, Clinic of Clinical Haematology, Sofia
Specialized Hospital for Active Treatment of Hematological Disease EAD,, Sofia
The Alfred Hospital, Melbourne
Princess Alexandra Hospital - Cancer Trials Unit, Brisbane
Haukeland University Hospital, Bergen
"University Multiprofile Hospital for Active Treatment Sveti Georgi EAD, Plovdiv, Clinic of Medical oncology", Pleven
AZ Nikolaas, Sint-Niklaas
Lombardi Comprehensive Cancer Center, Washington D.C.
Fondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico di Milano - UO Ematologia, Milan
Clinical Centre of Vojvodina, Clinic for Hematology, Novi Sad
John Hopkins Bayview Medical Center, Baltimore
"SCDU Ematologia AOU Maggiore della Carità", Novara
CHU de Bordeaux - GH Sud- Hôpital Haut Lévêque Service Médecine Interne et Maladies Infectieuses, Pessac
Universitätsklinikum Essen, Essen
City Clinical Hospital № 4, Hematology Center, Dnipro
Fakultni nemocnice Ostrava Klinika hematoonkologie, Ostrava
Comprehensive Cancer Centers of Nevada, Las Vegas
University of Southern California - Janice and Robert Hall Clinical Trials Biospecimen Laboratory, Los Angeles
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
University of Washington, Seattle
American Oncology Network Vista Oncology Division, Olympia
National Research Center for Hematology, Moscow
Vitebsk Regional Clinical Hospital, Vitebsk
Vitebsk Regional Clinical Oncology Dispensary, Vitebsk
State Budgetary Healthcare Institution Oncology Dispensary No. 2 of the Ministry of Health of the Krasnodar Territory, Sochi
Massachusetts General Hospital, Boston
Universitätsklinik f. Innere Medizin I - Klin. Abt. f. Hämatologie u. Hämostaseologie, Vienna
Fakultni nemocnice Brno Interni hematologicka a onkologicka klinika, Brno
LTD Multiprofile Clinic Consilium Medulla, Tbilisi
M. Zodelava Hematology Centre, Tbilisi, Tbilisi
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, UO Ematologia, Milan
Academisch Medisch Centrum, Amsterdam
Hospital Vall d'Hebron, Barcelona
Hospital Clinic de Barcelona, Barcelona
Kyiv City Clinical Hospital №9, hematology department №1, Kyiv
Roald Dahl Haemostasis and Thrombosis Centre, Royal Liverpool University Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool
Lead Sponsor
Rigel Pharmaceuticals
INDUSTRY